Loading company…
Navinci Diagnostics develops assays and tools for detecting proteins and protein interactions.
Founded in 2004 and based in Uppsala, Sweden, Navinci Diagnostics develops analytical methods and products for studying proteins and nucleic acids. Its Naveni technologies support target detection, staining, and analysis of protein interactions, including low-abundance proteins. In July 2022, the company raised SEK 90 million in Series A funding from Segulah Medical Acceleration, including Beijer Ventures, Landegren Gene Technology AB, and Nexttobe AB.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in